Literature DB >> 22788706

Characterization and carbohydrate specificity of pradimicin S.

Syed Shahzad-ul-Hussan1, Rodolfo Ghirlando, Cajetan I Dogo-Isonagie, Yasuhiro Igarashi, Jan Balzarini, Carole A Bewley.   

Abstract

The pradimicin family of antibiotics is attracting attention due to its anti-infective properties and as a model for understanding the requirements for carbohydrate recognition by small molecules. Members of the pradimicin family are unique among natural products in their ability to bind sugars in a Ca(2+)-dependent manner, but the oligomerization to insoluble aggregates that occurs upon Ca(2+) binding has prevented detailed characterization of their carbohydrate specificity and biologically relevant form. Here we take advantage of the water solubility of pradimicin S (PRM-S), a sulfated glucose-containing analogue of pradimicin A (PRM-A), to show by NMR spectroscopy and analytical ultracentrifugation that at biologically relevant concentrations, PRM-S binds Ca(2+) to form a tetrameric species that selectively binds and engulfs the trisaccharide Manα1-3(Manα1-6)Man over mannose or mannobiose. In functional HIV-1 entry assays, IC(50) values of 2-4 μM for PRM-S corrrelate with the concentrations at which oligomerization occurs as well as the affinities with which PRM-S binds the HIV surface envelope glycoprotein gp120. Together these data reveal the biologically active form of PRM-S, provide an explanation for previous speculations that PRM-A may contain a second mannose binding site, and expand our understanding of the characteristics that can engender a small molecule with the ability to function as a carbohydrate receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22788706      PMCID: PMC3422641          DOI: 10.1021/ja303860m

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  16 in total

1.  Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.

Authors:  Katie J Doores; Camille Bonomelli; David J Harvey; Snezana Vasiljevic; Raymond A Dwek; Dennis R Burton; Max Crispin; Christopher N Scanlan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Solid-state NMR spectroscopic analysis of the Ca2+-dependent mannose binding of pradimicin A.

Authors:  Yu Nakagawa; Yuichi Masuda; Keita Yamada; Takashi Doi; K Takegoshi; Yasuhiro Igarashi; Yukishige Ito
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-19       Impact factor: 15.336

3.  Mapping of the primary mannose binding site of pradimicin A.

Authors:  Yu Nakagawa; Takashi Doi; Yuichi Masuda; K Takegoshi; Yasuhiro Igarashi; Yukishige Ito
Journal:  J Am Chem Soc       Date:  2011-10-06       Impact factor: 15.419

4.  Structural basis for norovirus inhibition and fucose mimicry by citrate.

Authors:  Grant S Hansman; Syed Shahzad-Ul-Hussan; Jason S McLellan; Gwo-Yu Chuang; Ivelin Georgiev; Takashi Shimoike; Kazuhiko Katayama; Carole A Bewley; Peter D Kwong
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

5.  Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.

Authors:  Moriz Mayer; Bernd Meyer
Journal:  Angew Chem Int Ed Engl       Date:  1999-06-14       Impact factor: 15.336

6.  Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.

Authors:  Jason S McLellan; Marie Pancera; Chris Carrico; Jason Gorman; Jean-Philippe Julien; Reza Khayat; Robert Louder; Robert Pejchal; Mallika Sastry; Kaifan Dai; Sijy O'Dell; Nikita Patel; Syed Shahzad-ul-Hussan; Yongping Yang; Baoshan Zhang; Tongqing Zhou; Jiang Zhu; Jeffrey C Boyington; Gwo-Yu Chuang; Devan Diwanji; Ivelin Georgiev; Young Do Kwon; Doyung Lee; Mark K Louder; Stephanie Moquin; Stephen D Schmidt; Zhi-Yong Yang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Dennis R Burton; Wayne C Koff; Laura M Walker; Sanjay Phogat; Richard Wyatt; Jared Orwenyo; Lai-Xi Wang; James Arthos; Carole A Bewley; John R Mascola; Gary J Nabel; William R Schief; Andrew B Ward; Ian A Wilson; Peter D Kwong
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

7.  Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Authors:  Ming Li; Feng Gao; John R Mascola; Leonidas Stamatatos; Victoria R Polonis; Marguerite Koutsoukos; Gerald Voss; Paul Goepfert; Peter Gilbert; Kelli M Greene; Miroslawa Bilska; Denise L Kothe; Jesus F Salazar-Gonzalez; Xiping Wei; Julie M Decker; Beatrice H Hahn; David C Montefiori
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.

Authors:  Claire Bertaux; Dirk Daelemans; Laurent Meertens; Emmanuel G Cormier; John F Reinus; Willy J Peumans; Els J M Van Damme; Yasuhiro Igarashi; Toshikazu Oki; Dominique Schols; Tatjana Dragic; Jan Balzarini
Journal:  Virology       Date:  2007-05-11       Impact factor: 3.616

9.  Glycosylation site-specific analysis of clade C HIV-1 envelope proteins.

Authors:  Eden P Go; Qing Chang; Hua-Xin Liao; Laura L Sutherland; S Munir Alam; Barton F Haynes; Heather Desaire
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

10.  Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.

Authors:  Jan Balzarini; Katrien O François; Kristel Van Laethem; Bart Hoorelbeke; Marleen Renders; Joeri Auwerx; Sandra Liekens; Toshikazu Oki; Yasuhiro Igarashi; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

View more
  5 in total

Review 1.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

2.  Carbohydrate Recognition Specificity of Trans-sialidase Lectin Domain from Trypanosoma congolense.

Authors:  Mario Waespy; Thaddeus T Gbem; Leroy Elenschneider; André-Philippe Jeck; Christopher J Day; Lauren Hartley-Tassell; Nicolai Bovin; Joe Tiralongo; Thomas Haselhorst; Sørge Kelm
Journal:  PLoS Negl Trop Dis       Date:  2015-10-16

3.  An Engineered Microvirin Variant with Identical Structural Domains Potently Inhibits Human Immunodeficiency Virus and Hepatitis C Virus Cellular Entry.

Authors:  Munazza Shahid; Amina Qadir; Jaewon Yang; Izaz Ahmad; Hina Zahid; Shaper Mirza; Marc P Windisch; Syed Shahzad-Ul-Hussan
Journal:  Viruses       Date:  2020-02-11       Impact factor: 5.048

4.  Mannose-binding analysis and biological application of pradimicins.

Authors:  Yu Nakagawa; Yukishige Ito
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2022       Impact factor: 3.493

Review 5.  Molecular architecture and therapeutic potential of lectin mimics.

Authors:  Yu Nakagawa; Ito Yukishige
Journal:  Adv Carbohydr Chem Biochem       Date:  2012       Impact factor: 12.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.